Private Equity Archives - Gilde Healthcare

Menu
Menu
Home

latest news
Private Equity

Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.
May 19, 2022

Gilde Healthcare raises more than €500 million for private equity investments in European healthcare companies

test Gilde Healthcare Private Equity IV raises €517 million for investments in healthcare companies in the lower mid-market in Northwest Europe Gilde Healthcare has raised €933 million ($1.0 billion) in two years for its private equity and transatlantic venture&growth funds Gilde Healthcare today announces it raised €517 million towards the first and final close of Gilde […]

The Private Equity fund of Gilde Healthcare acquires medtech contract manufacturer EUROPIN

test Combination with portfolio company Acti-Med creates joint group representing one of the largest contract manufacturers of raw cannulas and cannula systems in Europe The acquisition of EUROPIN represents a major step for Gilde Healthcare in forming a leading integrated contract manufacturer for tailor-made cannulas and cannula systems, following its initial investment in German medtech company […]

Gilde Healthcare Private Equity as part of Investor Consortium acquires DETAX

Specialist for medical polymer materials DETAX resolves ownership succession in the course of a management buy-out and continues its successful growth track together with a strong Investor Consortium  ·    DETAX is a leading global supplier of biocompatible silicones and light-curing 3D resins for medical applications in the...

Gilde Healthcare’s Private Equity fund sells majority stake in European CRO/CDMO Symeres to Keensight Capital

Keensight Capital, one of the principal private equity managers dedicated to pan-European Growth Buyout1 investments, has reached an agreement to invest alongside management in Symeres, a leading European drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). According to the terms of the...

Gilde Healthcare acquires majority stake in Danish drug development consultancy KLIFO to support international growth ambitions

Northern European integrated drug development consultancy aims to further expand service offering and geographical footprint Utrecht (the Netherlands) and Copenhagen (Denmark) – Gilde Healthcare, a specialized healthcare investor, and KLIFO A/S, a leading Northern European drug development consultancy with significant experience in partnering with biotech and pharmaceutical...

The Private Equity fund of Gilde Healthcare acquires German medtech company Acti-Med

Investment to support the global expansion of leading manufacturer of precision medical components and devices Utrecht (the Netherlands) and Freienstau – The Private Equity fund of Gilde Healthcare, a specialist healthcare investor, has acquired Acti-Med, a leading international developer and contract manufacturer of high-quality medical components and...

Gilde Healthcare supports national roll out of dental chain Tandarts Today

Utrecht and Eindhoven (the Netherlands) – Gilde Healthcare, a specialized healthcare investor with €1.4 billion under management, announces its investment in dental chain Tandarts Today. With this acquisition, Gilde Healthcare enters the Dutch Dental Care Market with its attractive market dynamics and prevailing growth opportunities. Eindhoven-based Tandarts...

RAD-x adds Medizin Center Bonn to its fast growing diagnostic imaging platform

Utrecht (the Netherlands) and Mannheim (Germany) – RAD-x, the leading European diagnostic imaging practice operator and portfolio company of Gilde Healthcare Private Equity, is adding Medizin Center Bonn (MCB) to its group. MCB provides cutting-edge premier nuclear medicine- and radiology services in the region of Bonn, NRW,...
Loading...
These were all messages
948dba4ec6